Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Fennec Pharmaceuticals Receives U.S. FDA Orphan Drug Exclusivity for Pedmark® (Sodium Thiosulfate Injection)
Wednesday, February 01, 2023Fennec Pharmaceuticals announced that the US Food and Drug Administration FDA has granted Orphan Drug Exclusivity to PEDMARK sodium thiosulfate injection indicated to reduce the risk of ototoxicity or hearing loss associated with cisplatin use in pae...
Ascletis Announces U.S. FDA Approval for Conducting a Phase IIa Clinical Trial
Wednesday, February 01, 2023Ascletis Pharma announced that the US Food and Drug Administration FDA has approved to conduct a Phase IIa clinical trial for ASC to treat respiratory syncytial virus RSV infection Based on available data dosage of mg ASC twice daily was selected to...
Hillstream BioPharma Signs Option Agreement to Advance Next-Generation Anti-MUC1-C Agents
Wednesday, February 01, 2023Hillstream BioPharma announced signing an exclusive option agreement with DanaFarber Cancer Institute to licence technology targeting the MUCC oncoprotein This agreement allows Hillstream to leverage Quatramer platform to advance antiMUCC agents targ...
Sun Pharma Acquires Disperzyme® And Phlogam® Brands
Tuesday, January 31, 2023Sun Pharmaceutical announced that it has acquired three brands viz Disperzyme Trypsin BP mg Bromelain mg Rutoside Trihydrate mg DisperzymeCD Trypsin BP mg Bromelain mg Rutoside Trihydrate mg and Phlogam Trypsin BP mg Bromelain mg Rutoside...
Charles River Completes Acquisition of SAMDI Tech
Tuesday, January 31, 2023Charles River announced the acquisition of SAMDI Tech The acquisition is the culmination of an exclusive partnership between the companies started in The acquisition of SAMDI Techs cuttingedge highthroughput screening technology further strengthens...
Xeris Biopharma Grants FDA Orphan-drug Exclusivity for Recorlev®
Tuesday, January 31, 2023Xeris Biopharma Holdings announced that the Food and Drug Administration FDA granted its subsidiary Xeris Pharmaceuticals orphandrug exclusivity ODE for Recorlev levoketoconazole for the treatment of adult patients with endogenous Cushings syndrome w...
UniQure and Apic Bio Enter Licencing Agreement for APB-102
Tuesday, January 31, 2023UniQure NV and Apic Bio announced that they have entered into a global licencing agreement for APB to treat superoxide dismutase SOD amyotrophic lateral sclerosis ALS a rare genetic form of ALS Under the agreement uniQure will acquire worldwide righ...
Dupixent® (Dupilumab) Approved as The First And Only Targeted Medicine For Eosinophilic Oesophagitis
Monday, January 30, 2023The European Commission EC has expanded the marketing authorisation for Dupixent dupilumab in the European Union EU to treat eosinophilic oesophagitis EoE in adults and adolescents years and older weighing at least kg for those inadequately control...
CytomX Therapeutics Announces Probody® T-Cell Engaging Bispecific (TCB) Achievement in Collaboration with Astellas
Friday, January 27, 2023CytomX Therapeutics Inc today announced that it has achieved a clinical candidate milestone under its TCB agreement with Astellas The clinical candidate is the first Probody TCB molecule to progress in the collaboration and will trigger a million do...
Evotec Enters into Agreement with Janssen
Friday, January 27, 2023Evotec SE announced a strategic collaboration and licence agreement with Janssen Biotech Inc Janssen one of the Janssen Pharmaceutical Companies of Johnson Johnson The collaboration mainly focuses on the development of firstinclass targeted immuneba...
